Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.

Coronaviruses infect animals and humans causing a wide range of diseases. The diversity of coronaviruses in many mammalian species is contributed by relatively high mutation and recombination rates during replication. This dynamic nature of coronaviruses may facilitate cross-species transmission and...

Full description

Bibliographic Details
Main Authors: Yunjeong Kim, Hongwei Liu, Anushka C Galasiti Kankanamalage, Sahani Weerasekara, Duy H Hua, William C Groutas, Kyeong-Ok Chang, Niels C Pedersen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-03-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC4814111?pdf=render
_version_ 1818158752469090304
author Yunjeong Kim
Hongwei Liu
Anushka C Galasiti Kankanamalage
Sahani Weerasekara
Duy H Hua
William C Groutas
Kyeong-Ok Chang
Niels C Pedersen
author_facet Yunjeong Kim
Hongwei Liu
Anushka C Galasiti Kankanamalage
Sahani Weerasekara
Duy H Hua
William C Groutas
Kyeong-Ok Chang
Niels C Pedersen
author_sort Yunjeong Kim
collection DOAJ
description Coronaviruses infect animals and humans causing a wide range of diseases. The diversity of coronaviruses in many mammalian species is contributed by relatively high mutation and recombination rates during replication. This dynamic nature of coronaviruses may facilitate cross-species transmission and shifts in tissue or cell tropism in a host, resulting in substantial change in virulence. Feline enteric coronavirus (FECV) causes inapparent or mild enteritis in cats, but a highly fatal disease, called feline infectious peritonitis (FIP), can arise through mutation of FECV to FIP virus (FIPV). The pathogenesis of FIP is intimately associated with immune responses and involves depletion of T cells, features shared by some other coronaviruses like Severe Acute Respiratory Syndrome Coronavirus. The increasing risks of highly virulent coronavirus infections in humans or animals call for effective antiviral drugs, but no such measures are yet available. Previously, we have reported the inhibitors that target 3C-like protease (3CLpro) with broad-spectrum activity against important human and animal coronaviruses. Here, we evaluated the therapeutic efficacy of our 3CLpro inhibitor in laboratory cats with FIP. Experimental FIP is 100% fatal once certain clinical and laboratory signs become apparent. We found that antiviral treatment led to full recovery of cats when treatment was started at a stage of disease that would be otherwise fatal if left untreated. Antiviral treatment was associated with a rapid improvement in fever, ascites, lymphopenia and gross signs of illness and cats returned to normal health within 20 days or less of treatment. Significant reduction in viral titers was also observed in cats. These results indicate that continuous virus replication is required for progression of immune-mediated inflammatory disease of FIP. These findings may provide important insights into devising therapeutic strategies and selection of antiviral compounds for further development for important coronaviruses in animals and humans.
first_indexed 2024-12-11T15:35:05Z
format Article
id doaj.art-e109fd72db904f9baf1f4c95c7706550
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-11T15:35:05Z
publishDate 2016-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-e109fd72db904f9baf1f4c95c77065502022-12-22T00:59:58ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742016-03-01123e100553110.1371/journal.ppat.1005531Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.Yunjeong KimHongwei LiuAnushka C Galasiti KankanamalageSahani WeerasekaraDuy H HuaWilliam C GroutasKyeong-Ok ChangNiels C PedersenCoronaviruses infect animals and humans causing a wide range of diseases. The diversity of coronaviruses in many mammalian species is contributed by relatively high mutation and recombination rates during replication. This dynamic nature of coronaviruses may facilitate cross-species transmission and shifts in tissue or cell tropism in a host, resulting in substantial change in virulence. Feline enteric coronavirus (FECV) causes inapparent or mild enteritis in cats, but a highly fatal disease, called feline infectious peritonitis (FIP), can arise through mutation of FECV to FIP virus (FIPV). The pathogenesis of FIP is intimately associated with immune responses and involves depletion of T cells, features shared by some other coronaviruses like Severe Acute Respiratory Syndrome Coronavirus. The increasing risks of highly virulent coronavirus infections in humans or animals call for effective antiviral drugs, but no such measures are yet available. Previously, we have reported the inhibitors that target 3C-like protease (3CLpro) with broad-spectrum activity against important human and animal coronaviruses. Here, we evaluated the therapeutic efficacy of our 3CLpro inhibitor in laboratory cats with FIP. Experimental FIP is 100% fatal once certain clinical and laboratory signs become apparent. We found that antiviral treatment led to full recovery of cats when treatment was started at a stage of disease that would be otherwise fatal if left untreated. Antiviral treatment was associated with a rapid improvement in fever, ascites, lymphopenia and gross signs of illness and cats returned to normal health within 20 days or less of treatment. Significant reduction in viral titers was also observed in cats. These results indicate that continuous virus replication is required for progression of immune-mediated inflammatory disease of FIP. These findings may provide important insights into devising therapeutic strategies and selection of antiviral compounds for further development for important coronaviruses in animals and humans.http://europepmc.org/articles/PMC4814111?pdf=render
spellingShingle Yunjeong Kim
Hongwei Liu
Anushka C Galasiti Kankanamalage
Sahani Weerasekara
Duy H Hua
William C Groutas
Kyeong-Ok Chang
Niels C Pedersen
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
PLoS Pathogens
title Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
title_full Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
title_fullStr Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
title_full_unstemmed Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
title_short Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
title_sort reversal of the progression of fatal coronavirus infection in cats by a broad spectrum coronavirus protease inhibitor
url http://europepmc.org/articles/PMC4814111?pdf=render
work_keys_str_mv AT yunjeongkim reversaloftheprogressionoffatalcoronavirusinfectionincatsbyabroadspectrumcoronavirusproteaseinhibitor
AT hongweiliu reversaloftheprogressionoffatalcoronavirusinfectionincatsbyabroadspectrumcoronavirusproteaseinhibitor
AT anushkacgalasitikankanamalage reversaloftheprogressionoffatalcoronavirusinfectionincatsbyabroadspectrumcoronavirusproteaseinhibitor
AT sahaniweerasekara reversaloftheprogressionoffatalcoronavirusinfectionincatsbyabroadspectrumcoronavirusproteaseinhibitor
AT duyhhua reversaloftheprogressionoffatalcoronavirusinfectionincatsbyabroadspectrumcoronavirusproteaseinhibitor
AT williamcgroutas reversaloftheprogressionoffatalcoronavirusinfectionincatsbyabroadspectrumcoronavirusproteaseinhibitor
AT kyeongokchang reversaloftheprogressionoffatalcoronavirusinfectionincatsbyabroadspectrumcoronavirusproteaseinhibitor
AT nielscpedersen reversaloftheprogressionoffatalcoronavirusinfectionincatsbyabroadspectrumcoronavirusproteaseinhibitor